The story of Sildenafil presents a complex picture for shareholders. While the initial introduction generated substantial profits, the expiration of its intellectual property protection opened the floodgates to generic https://bookmarkindexing.com/story21517038/viagra-and-big-pharma-a-precarious-opportunity